My Quote Request
No products added yet
6505-01-097-4766
20 Products
NDC17314-9330-01
SODIUM CITRATE AND CITRIC ACID ORAL SOLUTION,USP
NSN, MFG P/N
6505010974766
NSN
6505-01-097-4766
NDC17314-9330-01
SODIUM CITRATE AND CITRIC ACID ORAL SOLUTION,USP
NSN, MFG P/N
6505010974766
NSN
6505-01-097-4766
MFG
CARDINAL HEALTH INC. DBA CARDINAL HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MG SODIUM CITRATE,DIHYDRATE PER 15 ML AND 1002.000 MG CITRIC ACID,MONOHYDRATE PER 15 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CITRATE AND CITRIC ACID ORAL SOLUTION USP 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES OR 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH ML CONTAINS 1 MEQ SODIUM ION AND IS EQUIVALENT TO 1 MEQ BICARBONATE (HCO3)
Related Searches:
NEBULO 28
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505010970001
NSN
6505-01-097-0001
NEBULO 28
WATER FOR INHALATION,STERILE,USP
NSN, MFG P/N
6505010970001
NSN
6505-01-097-0001
MFG
BARD C R INC INSPIRON DIV
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: WATER FOR INHALATION STERILE USP 1000ML BT 12 PER PG
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BAXTER HEALTHCARE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SPECIAL FEATURES: WITH NEBULIZER ADAPTER
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00641-0422-25
HYDROXYZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010970002
NSN
6505-01-097-0002
NDC00641-0422-25
HYDROXYZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010970002
NSN
6505-01-097-0002
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYZINE HYDROCHLORIDE INJECTION USP 50MG/ML 1ML BT 25 PER PG
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOOD,ELKINS-SINN
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
NDC00641-0433-25
HYDROXYZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010970002
NSN
6505-01-097-0002
NDC00641-0433-25
HYDROXYZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505010970002
NSN
6505-01-097-0002
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HYDROXYZINE HYDROCHLORIDE INJECTION USP 50MG/ML 1ML BT 25 PER PG
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOOD,ELKINS-SINN
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 25
Related Searches:
019-0954-T3
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505010970668
NSN
6505-01-097-0668
019-0954-T3
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505010970668
NSN
6505-01-097-0668
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.800 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III EXTERIOR CONTAINER CUBIC MEASURE: 0.767 CUBIC FEET
III EXTERIOR CONTAINER QUANTITY: 1
III EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOTHALAMATE SODIUM INJECTION USP 66.8% 50ML VIAL 50 PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: RADIOPAQUE CONTRAST MEDIUM FOR INTRAVENOUS UROGRAPHY INTRAVASCULAR ANGIOCARDIOGRAPHY AND AORTOGRAPHY
III UNIT OF ISSUE CUBE: 0.005 CUBIC FEET
III UNIT OF ISSUE WEIGHT: 0.06 POUNDS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
CONRAY-400
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505010970668
NSN
6505-01-097-0668
CONRAY-400
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505010970668
NSN
6505-01-097-0668
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.800 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III EXTERIOR CONTAINER CUBIC MEASURE: 0.767 CUBIC FEET
III EXTERIOR CONTAINER QUANTITY: 1
III EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOTHALAMATE SODIUM INJECTION USP 66.8% 50ML VIAL 50 PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: RADIOPAQUE CONTRAST MEDIUM FOR INTRAVENOUS UROGRAPHY INTRAVASCULAR ANGIOCARDIOGRAPHY AND AORTOGRAPHY
III UNIT OF ISSUE CUBE: 0.005 CUBIC FEET
III UNIT OF ISSUE WEIGHT: 0.06 POUNDS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
NDC00019-0954-15
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505010970668
NSN
6505-01-097-0668
NDC00019-0954-15
IOTHALAMATE SODIUM INJECTION,USP
NSN, MFG P/N
6505010970668
NSN
6505-01-097-0668
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 66.800 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III EXTERIOR CONTAINER CUBIC MEASURE: 0.767 CUBIC FEET
III EXTERIOR CONTAINER QUANTITY: 1
III EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOTHALAMATE SODIUM INJECTION USP 66.8% 50ML VIAL 50 PER PG
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III SUPPLEMENTARY FEATURES: RADIOPAQUE CONTRAST MEDIUM FOR INTRAVENOUS UROGRAPHY INTRAVASCULAR ANGIOCARDIOGRAPHY AND AORTOGRAPHY
III UNIT OF ISSUE CUBE: 0.005 CUBIC FEET
III UNIT OF ISSUE WEIGHT: 0.06 POUNDS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 50
UNIT PACKAGE TYPE: PACKAGE
Related Searches:
CUPRIMINE
PENICILLAMINE CAPSULES,USP
NSN, MFG P/N
6505010971232
NSN
6505-01-097-1232
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS PENICILLAMINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENICILLAMINE CAPSULES USP 125MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CUPRIMINE CAPSULES
PENICILLAMINE CAPSULES,USP
NSN, MFG P/N
6505010971232
NSN
6505-01-097-1232
CUPRIMINE CAPSULES
PENICILLAMINE CAPSULES,USP
NSN, MFG P/N
6505010971232
NSN
6505-01-097-1232
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS PENICILLAMINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENICILLAMINE CAPSULES USP 125MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00006-0672-68
PENICILLAMINE CAPSULES,USP
NSN, MFG P/N
6505010971232
NSN
6505-01-097-1232
NDC00006-0672-68
PENICILLAMINE CAPSULES,USP
NSN, MFG P/N
6505010971232
NSN
6505-01-097-1232
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 125.000 MILLIGRAMS PENICILLAMINE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PENICILLAMINE CAPSULES USP 125MG 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00006-0650-68
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
NDC00006-0650-68
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CARBIDOPA ACTIVE INGREDIENT AND 100.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARBIDOPA AND LEVODOPA TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00056-0650-68
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
NDC00056-0650-68
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CARBIDOPA ACTIVE INGREDIENT AND 100.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARBIDOPA AND LEVODOPA TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SINEMET
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
SINEMET
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CARBIDOPA ACTIVE INGREDIENT AND 100.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARBIDOPA AND LEVODOPA TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SINEMET TABLETS
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
SINEMET TABLETS
CARBIDOPA AND LEVODOPA TABLETS,USP
NSN, MFG P/N
6505010971233
NSN
6505-01-097-1233
MFG
BRISTOL-MYERS SQUIBB PHARMA COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CARBIDOPA ACTIVE INGREDIENT AND 100.000 MILLIGRAMS LEVODOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CARBIDOPA AND LEVODOPA TABLETS USP 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC11538-2019-00
IODINE COMPLEX SOLUTION
NSN, MFG P/N
6505010971335
NSN
6505-01-097-1335
NDC11538-2019-00
IODINE COMPLEX SOLUTION
NSN, MFG P/N
6505010971335
NSN
6505-01-097-1335
MFG
AMERICAN STERILIZER COMPANY DBA AMSCO STERILITY ASSURANCE PRODUCTS
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE, PLASTIC
QUANTITY WITHIN EACH UNIT PACKAGE: 6.0 FLUID OUNCES
SOLUTE EQUIVALENT IN PERCENT: 1.0 IODINE
UNIT PACKAGE QUANTITY: 1 BOTTLE
Related Searches:
NH004
IODINE COMPLEX SOLUTION
NSN, MFG P/N
6505010971335
NSN
6505-01-097-1335
MFG
AMERICAN STERILIZER COMPANY DBA AMSCO STERILITY ASSURANCE PRODUCTS
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE, PLASTIC
QUANTITY WITHIN EACH UNIT PACKAGE: 6.0 FLUID OUNCES
SOLUTE EQUIVALENT IN PERCENT: 1.0 IODINE
UNIT PACKAGE QUANTITY: 1 BOTTLE
Related Searches:
PREPODYNE SOLUTION
IODINE COMPLEX SOLUTION
NSN, MFG P/N
6505010971335
NSN
6505-01-097-1335
PREPODYNE SOLUTION
IODINE COMPLEX SOLUTION
NSN, MFG P/N
6505010971335
NSN
6505-01-097-1335
MFG
AMERICAN STERILIZER COMPANY DBA AMSCO STERILITY ASSURANCE PRODUCTS
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOTTLE, PLASTIC
QUANTITY WITHIN EACH UNIT PACKAGE: 6.0 FLUID OUNCES
SOLUTE EQUIVALENT IN PERCENT: 1.0 IODINE
UNIT PACKAGE QUANTITY: 1 BOTTLE
Related Searches:
NDC00015-3072-20
CISPLATIN FOR INJECTION
NSN, MFG P/N
6505010972935
NSN
6505-01-097-2935
NDC00015-3072-20
CISPLATIN FOR INJECTION
NSN, MFG P/N
6505010972935
NSN
6505-01-097-2935
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CISPLATIN ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
PLATINOL
CISPLATIN FOR INJECTION
NSN, MFG P/N
6505010972935
NSN
6505-01-097-2935
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS CISPLATIN ACTIVE INGREDIENT
III PROTECTIVE STORAGE FEATURE: ANTINEOPLASTIC DRUG
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLIGRAMS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00121-0595-16
SODIUM CITRATE AND CITRIC ACID ORAL SOLUTION,USP
NSN, MFG P/N
6505010974766
NSN
6505-01-097-4766
NDC00121-0595-16
SODIUM CITRATE AND CITRIC ACID ORAL SOLUTION,USP
NSN, MFG P/N
6505010974766
NSN
6505-01-097-4766
MFG
PHARMACEUTICAL ASSOCIATES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1500.000 MG SODIUM CITRATE,DIHYDRATE PER 15 ML AND 1002.000 MG CITRIC ACID,MONOHYDRATE PER 15 ML
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CITRATE AND CITRIC ACID ORAL SOLUTION USP 473ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES OR 473.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: EACH ML CONTAINS 1 MEQ SODIUM ION AND IS EQUIVALENT TO 1 MEQ BICARBONATE (HCO3)
